6533b859fe1ef96bd12b7f47
RESEARCH PRODUCT
Neutralizing human antibodies against CD55 and CD59 targeted to lymphoma cells in vivo potentiate the therapeutic effect of Rituximab
Roberto MarzariPaolo MacorAlberto AmadoriClaudio TripodoSonia ZorzetFrancesco TedescoErich Piovansubject
biologybusiness.industryImmunologyTherapeutic effectCD59medicine.diseaseLymphomaIn vivoImmunologymedicinebiology.proteinRituximabAntibodybusinessMolecular Biologymedicine.drugyear | journal | country | edition | language |
---|---|---|---|---|
2007-01-01 | Molecular Immunology |